Algeron
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Algeron, covering 2015-07-21 to 2018-07-16. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C [Phase 3]